An inherited NBN mutation is associated with poor prognosis prostate cancer-Reference-Cited by-同舟云学术

An inherited NBN mutation is associated with poor prognosis prostate cancer

Published:2012-11-13 Issue:2 Volume:108 Page:461-468
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cybulski C, ,Wokołorczyk D,Kluźniak W,Jakubowska A,Górski B,Gronwald J,Huzarski T,Kashyap A,Byrski T,Dębniak T,Gołąb A,Gliniewicz B,Sikorski A,Świtała J,Borkowski T,Borkowski A,Antczak A,Wojnar Ł,Przybyła J,Sosnowski M,Małkiewicz B,Zdrojowy R,Sikorska-Radek P,Matych J,Wilkosz J,Różański W,Kiś J,Bar K,Bryniarski P,Paradysz A,Jersak K,Niemirowicz J,Słupski P,Jarzemski P,Skrzypczyk M,Dobruch J,Domagała P,Narod S A,Lubiński J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2012486.pdf

Reference46 articles.

1. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chow WH, Rothman N, Chabrier A, Gaborieau V, Odefrey F, Southey M, Hashibe M, Hall J, Boffetta P, Peto J, Peto R, Hung RJ (2007) Uncommon CHEK2 missense variant and reduced risk of tobacco-related cancers: Case control study. Hum Mol Genet 16: 1794–1801

2. Chrzanowska KH, Piekutowska-Abramczuk D, Popowska E, Gładkowska-Dura M, Małdyk J, Syczewska M, Krajewska-Walasek M, Goryluk-Kozakiewicz B, Bubała H, Gadomski A, Gaworczyk A, Kazanowska B, Kołtan A, Kuźmicz M, Luszawska-Kutrzeba T, Maciejka-Kapuścińska L, Stolarska M, Stefańska K, Sznurkowska K, Wakulińska A, Wieczorek M, Szczepański T, Kowalczyk J (2006) Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int J Cancer 118: 1269–1274

3. Cybulski C, Górski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojć B, Jakubowska A, Matyjasik J, Złowocka E, Sikorski A, Narod SA, Lubiński J (2004) NBS1 is a prostate cancer susceptibility gene. Cancer Res 64: 1215–1219

4. Cybulski C, Wokołorczyk D, Huzarski T, Byrski T, Gronwald J, Górski B, Debniak T, Masojć B, Jakubowska A, Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Zdrojowy R, Małkiewicz B, Borkowski A, Borkowski T, Szwiec M, Narod SA, Lubiński J (2006) A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet 43: 863–866

5. Cybulski C, Wokołorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Masojć B, Debniak T, Górski B, Blecharz P, Narod SA, Lubiński J (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29: 3747–3752

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics of prostate cancer: a review of latest evidence;Journal of Medical Genetics;2024-08-13

2. Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta‐analysis;International Journal of Cancer;2024-06-26

3. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival;European Urology Oncology;2024-04

4. Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer;Medicina;2023-12-30

5. Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer;Scientific Reports;2023-11-06